Defibrillator market size to reach US$ 13.54B by 2028

The global defibrillator market size is expected to reach USD 13.54 Billion by 2028, at a CAGR of 3.4% over the forecast period, according to the current analysis of Reports and Data. Major factors driving defibrillator market revenue growth are massive investments by private players, technological progressions, and an increase in the occurrence of cardiac disorders due to changes in lifestyle.

A defibrillator is a machine that delivers a high-energy electric shock to a person who is experiencing cardiac arrest. In emergency medicine, defibrillation is used to stop ventricular fibrillation or pulseless ventricular tachycardia. External, transvenous, and implanted defibrillators are available in the global defibrillator market, depending on the type of device used or required. Arrhythmias, or irregular cardiac rhythms, are detected by each type of device. Furthermore, one of the primary drivers of the defibrillator market is the rising occurrence of cardiac arrests and other cardiovascular problems, particularly irregular heartbeats. Various cardiology and medical organizations have imposed sanctions on the use of automated external defibrillators in public locations, resulting in a rapid increase in the adoption rate in industrialized countries. This trend is expected to continue throughout the projected period, presenting the fantastic potential for competitors in the global defibrillator market.

Patients are likely to adopt wearable cardioverter defibrillators as a temporary alternative or to bridge to a long-term implantable cardioverter-defibrillator installation as the demand for wearable cardioverter defibrillators grows.

 Further key findings from the report suggest:

• A defibrillator is used to improve the chances of survival by stopping or reducing these abrupt and premature deaths. Heart disease claims the lives of nearly 350,000 Americans each year. The majority of these deaths are caused by a phenomenon known as sudden cardiac arrest, which occurs with little or no warning.
• Defibrillators are extremely important in preventing such life-threatening situations. It is estimated that each minute of delayed defibrillation diminishes the odds of survival by 10%.
• In the defibrillator market, the implantable cardioverter-defibrillator had the largest market share of around 51.1 percent. The range of these devices has widened as additional technologies, such as pacemakers, have been integrated with defibrillators.
• North America’s high degree of technology developments and research helped the region to hold the greatest share in 2020, boosting the global defibrillator market growth.
• Outside of a medical setting, the survival rate is only about 1% to 5%, but the chances of survival increase dramatically if they can be treated with an AED right away.
• Because implantable defibrillators are generally available in hospitals, hospitals have made a significant contribution to the rise of implantable and external defibrillators. As a result, hospitals made up the majority of the defibrillator market.

Competitive landscape:
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The Defibrillator market is extremely competitive and consists of several key players at the regional and global levels. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures, and collaborations to strengthen their market position and enhance their product portfolio.

Leading companies operating in the market are:
Medtronic, Jude Medical LLC, Boston Scientific Corporation, LivaNova, Koninklijke Philips, ZOLL Medical Corporation, Cardiac Science, Physio-Control, Nihon Kohden Corporation, Defibtech, HeartSine Technologies, Progetti Srl, Fukuda Denshi Co, and Schiller AG. Reports and Data